Orange Book product · Brand (NDA)
ZOLPIMIST
ZOLPIDEM TARTRATE
At a glance
Dec 19, 2008
Approved
Brand (NDA)
Application
Not listed
TE code
1
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 19, 2008
17 yr 9 mo ago
Today
Patent 8236285 expires
Listed drug substance patent expiration.
Aug 07, 2032
in 6 yr 3 mo
Pharmaceutical detail
Active ingredient
ZOLPIDEM TARTRATE
Strength
5MG/SPRAY
Dosage form
SPRAY, METERED
Route
ORAL
TE code
Not listed
Application
NDA 022196
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2023ZOLPIDEM TARTRATEBrand (NDA)
NDA 215721 · ALMATICA
- 2011INTERMEZZOBrand (NDA)
NDA 022328 · PURDUE PHARMA
- 2009EDLUARBrand (NDA)
NDA 021997 · VIATRIS
- 2007TOVALT ODTBrand (NDA)
NDA 021412 · BIOVAIL LABS INTL
- 2005AMBIEN CRBrand (NDA)
NDA 021774 · COSETTE
- 1992AMBIENBrand (NDA)
NDA 019908 · COSETTE
- 2026ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 220717 · UMEDICA LABS PVT
- 2020ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 213592 · BRECKENRIDGE
- 2017ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 204229 · PH HEALTH
- 2017ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 204170 · SUN PHARM
- 2016ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 204503 · DR REDDYS
- 2016ZOLPIDEM TARTRATEGeneric (ANDA)
ANDA 202657 · PHARMOBEDIENT
Listed patents (1)
| Patent | Expires | In | Type |
|---|---|---|---|
| 8236285 | Aug 07, 2032 | in 6 yr 3 mo | SubstanceProductU-70 |

